JonathanDaytonBermanMD

PubMed

• The Tropical Disease Priority Review Voucher: A Game-Changer for Tropical Disease Products.
  Berman J, Radhakrishna T> ;Am. J. Trop. Med. Hyg.. 2016-08-29
• Intralesional Pentamidine: A Novel Therapy for Single Lesions of Bolivian Cutaneous Leishmaniasis.
  Soto J, Paz D, Rivero D, Soto P, Quispe J, Toledo J, Berman J> ;Am. J. Trop. Med. Hyg.. 2016-04-01
• Amphotericin B formulations and other drugs for visceral leishmaniasis.
  Berman J> ;Am. J. Trop. Med. Hyg.. 2015-03-01
• Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
  DiTusa C, Kozar MP, Pybus B, Sousa J, Berman J, Gettayacamin M, Im-erbsin R, Tungtaeng A, Ohrt C> ;J. Parasitol.. 2014-10-01
• Reply to Monge-Maillo et al.
  Soto J, Berman J> ;Clin. Infect. Dis.. 2013-11-01
• Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama.
  Sosa, N.,Capitán, Z.,Nieto, J.,Nieto, M.,Calzada, J.,Paz, H.,Spadafora, C.,Kreishman-Deitrick, M.,Kopydlowski, K.,Ullman, D.,McCarthy, W. F.,Ransom, J.,Berman, J.,Scot...> ;Am. J. Trop. Med. Hyg.. 2013 Sep
• Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.
  Soto J, Rojas E, Guzman M, Verduguez A, Nena W, Maldonado M, Cruz M, Gracia L, Villarroel D, Alavi I, Toledo J, Berman J> ;Clin. Infect. Dis.. 2013-05-01
• Drug discovery algorithm for cutaneous leishmaniasis.
  Grogl, M.,Hickman, M.,Ellis, W.,Hudson, T.,Lazo, J. S.,Sharlow, E. R.,Johnson, J.,Berman, J.,Sciotti, R. J.> ;Am J Trop Med Hyg. 2013 Feb
• Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
  Ben Salah, A.,Ben Messaoud, N.,Guedri, E.,Zaatour, A.,Ben Alaya, N.,Bettaieb, J.,Gharbi, A.,Belhadj Hamida, N.,Boukthir, A.,Chlif, S.,Abdelhamid, K.,El Ahmadi, Z.,Louz...> ;N Engl J Med. 2013 Feb 7
• Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.
  Sundar S, Sinha P, Jha TK, Chakravarty J, Rai M, Kumar N, Pandey K, Narain MK, Verma N, Das VNR, Das P, Berman J, Arana B> ;Trop. Med. Int. Health. 2013-01-01
• 96 citations
  Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
  Jaime Soto, Jaime Rea, Margarita Balderrama, J. Toledo, Paula Soto, Luis Valda, Jonathan D. Berman> ;The American Journal of Tropical Medicine and Hygiene. 2008 Feb 1
• Treatment of Bolivian mucosal leishmaniasis with miltefosine.
  Soto J, Toledo J, Valda L, Balderrama M, Rea I, Parra R, Ardiles J, Soto P, Gomez A, Molleda F, Fuentelsaz C, Anders G, Sindermann H, Engel J, Berman J> ;Clin. Infect. Dis.. 2007-02-01
• Treatment of New World cutaneous leishmaniasis with miltefosine.
  Soto J, Berman J> ;Trans. R. Soc. Trop. Med. Hyg.. 2006-12-01
• Miltefosine: issues to be addressed in the future.
  Berman J, Bryceson ADM, Croft S, Engel J, Gutteridge W, Karbwang J, Sindermann H, Soto J, Sundar S, Urbina JA> ;Trans. R. Soc. Trop. Med. Hyg.. 2006-12-01
• Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
  Soto J, Toledo J, Vega J, Berman J> ;Am. J. Trop. Med. Hyg.. 2005-04-01
• 67 citations
  COMPARISON OF MEGLUMINE ANTIMONIATE AND PENTAMIDINE FOR PERUVIAN CUTANEOUS LEISHMANIASIS
  Ellen M. Andersen, Maria Cruz-Saldarriaga, Alejandro Llanos-Cuentas, Maria Luz-Cjuno, Juan Echevarria, Cesar Miranda-Verastegui, Olga Colina, Jonathan D. Berman> ;The American Journal of Tropical Medicine and Hygiene. 2005 Feb 1
• Putting clinical trials into context.
  Berman J> ;Lancet. 2005-01-01
• Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
  Soto J, Valda-Rodriquez L, Toledo J, Vera-Navarro L, Luz M, Monasterios-Torrico H, Vega J, Berman J> ;Am. J. Trop. Med. Hyg.. 2004-11-01
• Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.
  Bhattacharya, S.K., Jha, T.K., Sundar, S., Thakur, C.P., Engel, J., Sindermann, H., Junge, K., Karbwang, J., Bryceson, A.M., Berman, J.D.> ;Clin Infect Dis. 2004 Jan 15
• Implementing a research agenda for complementary and alternative medicine.
  Berman, J.D., Straus, S.E.> ;Annu Rev Med. 2004
• 52 citations
  Noninvasive Management of Indian Visceral Leishmaniasis: Clinical Application of Diagnosis by K39 Antigen Strip Testing at a Kala-azar Referral Unit
  Shyam Sundar, M. Sahu, H. Mehta, Abhishek Gupta, U. Kohli, Madhukar Rai, Jonathan D. Berman, Henry W. Murray> ;Clinical Infectious Diseases. 2002 Sep 1
• 58 citations
  Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study.
  Jaime Soto, J. Toledo, Patricia Gutierrez, Margarita Arboleda, Ruben S Nicholls, Julio Padilla, Jonathan D. Berman, Charles K. English, Max Grogl> ;The American Journal of Tropical Medicine and Hygiene. 2002 Feb 1
• Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.
  Dietze R, Carvalho SF, Valli LC, Berman J, Brewer T, Milhous W, Sanchez J, Schuster B, Grogl M> ;Am. J. Trop. Med. Hyg.. 2001-12-01
• Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.
  Soto J, Toledo J, Gutierrez P, Nicholls RS, Padilla J, Engel J, Fischer C, Voss A, Berman J> ;Clin. Infect. Dis.. 2001-10-01
• Plasmodium vivax clinically resistant to chloroquine in Colombia.
  Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeño N, Dunne M, Berman J> ;Am. J. Trop. Med. Hyg.. 2001-08-01
• Join now to see all